Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Clinical Chemistry Podcast
05/11/2025 9 min
Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use

Listen "Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use"

Descargar episodio Ver en sitio original

Episode Synopsis

Ruben Y Luo, Priscilla S W Yeung, Morgan W Mann, Lichao Zhang, Yifei K Yang, Andrew N Hoofnagle, Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use, Clinical Chemistry, Volume 71, Issue 11, November 2025, Pages 1111–1124, https://doi.org/10.1093/clinchem/hvaf094

More episodes of the podcast Clinical Chemistry Podcast

Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic Procedures 12/12/2025
Transdermal GFR Signals a New Horizon in Renal Diagnostics 08/12/2025
Modern Low-Density Lipoprotein Cholesterol Formulas Outperform Direct Methods in Patients with Hypertriglyceridemia and Low Levels of Low-Density Lipoprotein Cholesterol 20/11/2025
Audio Summary December 2025 17/11/2025
Embracing Generative Artificial Intelligence as a Support Tool for Clinical Decision-Making 05/11/2025
Diagnostic Value of Digital Estimates of Trophoblastic Mosaicism in Genome-Wide Cell-Free Fetal DNA Screening 21/10/2025
Risk vs Prevalence: Weighing Routine DPYD Variant Testing Prior to Fluoropyrimidine-Based Chemotherapy 21/10/2025
Audio Summary November 2025 20/10/2025
Optimizing Estimation: Perspective on Drug Dosing Using New CKD-EPI Equations 17/10/2025
Audio Summary October 2025 22/09/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA